We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
In This Issue.
- Abstract
An introduction is presented in which the editor discusses articles in the issue on topics including treatment attenuates murine lupus; use of IFNα as a driver of variability in primary Sjögren's syndrome (SS); and immune-mediated inflammatory diseases (IMID) patients with B cell depletion therapy susceptible to breakthrough COVID-19.
- Subjects
THERAPEUTIC use of interferons; COVID-19; B cells; RHEUMATOLOGY; SERIAL publications; AUTOIMMUNE diseases; HEALTH; INFORMATION resources; DISEASE susceptibility; ARTHRITIS; ACYCLIC acids; SYSTEMIC lupus erythematosus; SJOGREN'S syndrome
- Publication
Arthritis & Rheumatology, 2022, Vol 74, Issue 12, p1
- ISSN
2326-5191
- Publication type
Article
- DOI
10.1002/art.41871